Meeting
2019 Genitourinary Cancers Symposium
Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.
Authors
Naomi Y Jiang
University of California Los Angeles, Los Angeles, CA
Naomi Y Jiang , Christopher R. King , Alan J. Katz , Sean P. Collins , Nima Aghdam , Simeng Suy , Kevin L. Stephans , Chandana A. Reddy , Irving D. Kaplan , Limor Appelbaum , Audrey Dang , Ye Yuan , Nicholas George Nickols , Michael L. Steinberg , Patrick Kupelian , Amar Upadhyaya Kishan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 51)
DOI
10.1200/JCO.2019.37.7_suppl.51
Abstract #
51
Poster Bd #
C19
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
First Author: Luca Faustino Valle
Poster
2020 Genitourinary Cancers Symposium
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, survival, and late toxicity outcomes.
First Author: Andrew Loblaw
Poster
2018 Genitourinary Cancers Symposium
Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study.
First Author: Amar Upadhyaya Kishan
Poster
2017 Genitourinary Cancers Symposium
Management of high-risk prostate cancer with 5-treatment stereotactic body radiotherapy: Long-term results.
First Author: Josephine Kang